NCT06264414View on ClinicalTrials.gov

Efficacy and Safety of the DTT106 in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

262

Participants

Timeline

Start Date

February 28, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

July 31, 2027

Conditions
Prostatic Hyperplasia, BenignErectile Dysfunction
Interventions
DRUG

DTT106

oral route

DRUG

Dutasteride-Tamsulosin

oral route

Trial Locations (1)

Unknown

EMS, Hortolândia

Sponsors

Lead Sponsor

EMS
All Listed Sponsors
lead

EMS

INDUSTRY